The Procter & Gamble Company Quarterly Earnings Sneak Peek

S&P 500 (NYSE:SPY) component The Procter & Gamble Company (NYSE:PG) will unveil its latest earnings on Friday, August 5, 2011. Procter & Gamble Co. sells and markets consumer products such as pharmaceuticals, cleaning supplies, personal care, and pet supplies in more than 180 countries.

The Procter & Gamble Company Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 82 cents per share, a rise of 15.5% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 83 cents. Between one and three months ago, the average estimate moved down, but it has been unchanged at 82 cents during the last month. For the year, analysts are projecting net income of $3.93 per share, a rise of 7.1% from last year.

Past Earnings Performance: The company missed estimates last quarter after beating forecasts in the prior two. In the third quarter, the company reported profit of 96 cents per share versus a mean estimate of net income of 97 cents per share. In second quarter, the company beat estimates by 3 cents.

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>

Wall St. Revenue Expectations: On average, analysts predict $20.63 billion in revenue this quarter, a rise of 9% from the year ago quarter. Analysts are forecasting total revenue of $82.32 billion for the year, a rise of 4.3% from last year’s revenue of $78.94 billion.

Analyst Ratings: Analysts are bullish on this stock with 18 analysts rating it as a buy, one rating it as a sell and six rating it as a hold.

Key Stats:

The increase in profit in the third quarter breaks a streak of three consecutive quarters of year-over-year profit decreases. In the third quarter, net income rose 11.1% from the year earlier, while the figure dropped 28.5% in the second quarter, 6.8% in the first quarter and 11.6% in the fourth quarter of the last fiscal year.

Revenue has risen the past four quarters. Revenue increased 5.5% to $20.23 billion in third quarter. The figure rose 1.5% in the second quarter from the year earlier, climbed 1.6% in the first quarter from the year-ago quarter and 1.4% in the fourth quarter of the last fiscal year.

Competitors to Watch: Church & Dwight Co., Inc. (NYSE:CHD), Colgate-Palmolive Company (NYSE:CL), The Clorox Company (NYSE:CLX), Kimberly-Clark Corporation (NYSE:KMB), Johnson & Johnson (NYSE:JNJ), Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA), CCA Industries, Inc. (AMEX:CAW), and Zep, Inc. (NYSE:ZEP).

Stock Price Performance: During May 5, 2011 to August 1, 2011, the stock price had fallen $3.91 (-6%) from $65.34 to $61.43. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 4, 2011 when shares rose for nine-straight days, rising 5.9% (+$3.69) over that span. It saw one of its worst periods between July 21, 2011 and August 1, 2011 when shares fell for eight-straight days, falling 4.7% (-$3.06) over that span. Shares are down $1.39 (-2.2%) year to date.

(Source: Xignite Financials)

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>